Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.

@article{Bres2008AnalysisOP,
  title={Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.},
  author={Bern{\'a}t J{\'a}nos B{\'e}res and Emese T{\'o}th-Zs{\'a}mboki and Katar{\'i}na Vargov{\'a} and Ad{\'a}m L{\'a}szl{\'o} and Tamas Masszi and G{\'a}bor Kerecsen and Istv{\'a}n Pr{\'e}da and Robert Kiss},
  journal={Thrombosis and haemostasis},
  year={2008},
  volume={100 5},
  pages={829-38}
}
Combined antiplatelet therapy reduces recurrent atherothrombotic events in stable coronary disease patients; however, high residual platelet reactivity measured ex vivo still raises concerns as a condition related to treatment failure. Alpha-2 adrenoceptor enhances platelet reactivity and might contribute to this phenomenon. For the present study, 121… CONTINUE READING